Previous Article | Next Article 
Molecular and Cellular Biology, April 1999, p. 2986-2997, Vol. 19, No. 4
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
Role for Caspase-Mediated Cleavage of Rad51 in
Induction of Apoptosis by DNA Damage
YinYin
Huang,1
Shuji
Nakada,1
Takatoshi
Ishiko,1
Taiju
Utsugisawa,1
Rakesh
Datta,1
Surender
Kharbanda,1
Kiyotsugu
Yoshida,1
Robert V.
Talanian,2
Ralph
Weichselbaum,3
Donald
Kufe,1,* and
Zhi-Min
Yuan1
Dana-Farber Cancer Institute, Harvard Medical
School, Boston, Massachusetts 021151;
BASF Bioresearch Corp., Worcester, Massachusetts
016052; and Department of Radiation
and Cellular Oncology, University of Chicago, Chicago, Illinois
606373
Received 29 July 1998/Returned for modification 18 September
1998/Accepted 15 December 1998
 |
ABSTRACT |
We report here that the Rad51 recombinase is cleaved in mammalian
cells during the induction of apoptosis by ionizing radiation (IR)
exposure. The results demonstrate that IR induces Rad51 cleavage by a
caspase-dependent mechanism. Further support for involvement of
caspases is provided by the finding that IR-induced proteolysis of
Rad51 is inhibited by Ac-DEVD-CHO. In vitro studies show that Rad51 is
cleaved by caspase 3 at a DVLD/N site. Stable expression of a Rad51
mutant in which the aspartic acid residues were mutated to alanines
(AVLA/N) confirmed that the DVLD/N site is responsible for the cleavage
of Rad51 in IR-induced apoptosis. The functional significance of Rad51
proteolysis is supported by the finding that, unlike intact Rad51, the
N- and C-terminal cleavage products fail to exhibit recombinase
activity. In cells, overexpression of the Rad51(D-A) mutant had no
effect on activation of caspase 3 but did abrogate in part the
apoptotic response to IR exposure. We conclude that proteolytic
inactivation of Rad51 by a caspase-mediated mechanism contributes
to the cell death response induced by DNA damage.
 |
INTRODUCTION |
The response of eukaryotic cells to
ionizing radiation (IR) and other DNA-damaging agents includes the
induction of apoptosis. The available evidence indicates that IR
induces DNA lesions by direct interaction with DNA or through the
formation of reactive oxygen intermediates (27). However,
the basis by which cells recognize DNA damage and transduce this
information into signals that regulate events such as induction of
apoptosis remains unclear.
Direct evidence for the activation of caspases in the induction of
apoptosis comes from studies with peptide inhibitors (2, 52,
54), the cowpox virus protein CrmA (57), and the
baculovirus protein p35 (9). Overexpression of CrmA inhibits
the induction of apoptosis in diverse settings, including activation of
the Fas receptor and treatment with tumor necrosis factor alpha (TNF) (21, 41, 71). Similarly, the p35 protein functions as an inhibitor of caspases and blocks apoptosis in insect and mammalian cells (10, 14, 15, 55). The recent finding that IR-induced apoptosis involves activation of a CrmA-insensitive pathway has supported the existence of apoptotic signals that are distinct from
those activated by Fas and TNF (17). In this context,
caspase 3 is inhibited by p35 but not CrmA in vitro, and IR-induced
activation of caspase 3, like the induction of apoptosis,
involves a p35-sensitive, CrmA-insensitive pathway
(17). Whereas caspase 3 is activated by IR, as
well as Fas ligand and TNF, these findings are explained by
involvement of a CrmA-sensitive caspase in the Fas- and
TNF-induced, but not the IR-induced, cascade. IR-induced
activation of caspase 3 is associated with the proteolytic cleavage
of poly(ADP-ribose) polymerase (PARP) (29, 36, 47),
DNA-PK (11), protein kinase C
(20, 25), and
protein kinase C
(18). The activation of caspase 3 and the subsequent substrate cleavage in irradiated cells are
regulated by members of the Bcl-2/Bcl-xl family (17, 20). Bcl-2 and Bcl-xL block the release of cytochrome
c from the mitochondria of cells exposed to IR and other
agents (30, 32, 33, 78). Whereas cytochrome c is
not released from the mitochondria of cells induced to undergo
apoptosis with Fas ligand (13), this event upstream to
activation of caspase 3 (37) and the insensitivity of
IR-induced caspase-3 activity to CrmA (17) support
distinct apoptotic signals in Fas- and IR-treated cells.
The present work provides support for the involvement of the Rad51
protein in IR-induced apoptosis. The RecA protein in Escherichia coli mediates recombinational repair of DNA double-strand breaks by initiating pairing and strand exchange between homologous DNAs (62). The identification of structural homologs of RecA in
yeast, Xenopus laevis, mouse, and human cells has supported
conservation of similar repair functions (8, 43, 49, 60,
61). ScRad51, the RecA homolog in Saccharomyces
cerevisiae, is a member of the Rad52 epistasis group required for
genetic recombination and the repair of IR-induced DNA double-strand
breaks (61). ScRad51 converts DNA double-strand breaks to
recombinatorial intermediates, and these breaks accumulate in
rad51 mutants (61). In vitro, ScRad51 catalyzes
DNA strand exchange in a reaction that is dependent on ATP and the
single-strand binding factor replication protein A (67).
Other studies indicate that ScRad52 functions as a cofactor for the
Rad51 recombinase (46, 63, 66). Human Rad51 (HsRad51) also
binds DNA, promotes ATP-dependent homologous pairing and strand
transfer reactions in vitro, and interacts with Rad52 (4, 5,
26). These findings have suggested that Rad51 also plays a role
in recombinatorial repair in mammalian cells. In this context, decreased expression of Rad51 in mouse cells confers sensitivity to
IR-induced DNA lesions (69). Other studies in mice have
demonstrated that targeted disruption of the rad51 gene
results in an embryonic lethal phenotype (38, 73). Mutant
embryos arrest early in development and exhibit increased apoptosis
(38). Recent studies in chicken cells have further
demonstrated that Rad51 functions in the repair of spontaneously
occurring chromosome breaks in proliferating cells (64).
These findings and the failure to generate viable
rad51
/
embryonic stem cells (73)
have indicated that Rad51 function is essential for cell viability.
In the present studies, we show that Rad51 is cleaved at a DVLD/N
site by a caspase-mediated mechanism in IR-induced, but not
in TNF-induced, apoptosis. Cleavage of Rad51 to N- and C-terminal fragments abrogates Rad51 recombinase activity. Importantly, expression of a caspase-resistant Rad51 protects in part against IR-induced apoptosis. These findings support a role for the Rad51 protein in cell
death mechanisms induced by DNA damage.
 |
MATERIALS AND METHODS |
Cell culture.
U-937 cells, Rat1/myc cells, HeLa cells, MCF-7
cells, and 293 embryonal kidney cells were grown as described earlier
(31, 79). U2-OS cells (American Type Culture Collection)
were grown in McCoy's 5A medium supplemented with 10% fetal bovine
serum. Irradiation was performed by using a Gammacell 1000 (Atomic
Energy of Canada) with a 137Cs source emitting at a fixed
dose of 0.21 Gy min
1 as determined by dosimetry. The DNA
content was assessed by staining ethanol-fixed cells with propidium
iodide and monitoring with a FACScan (Becton Dickinson). Numbers of
cells with sub-G1 DNA content were determined with a MODFIT LT program
(Verity Software House, Topsham, Maine). Statistical analysis of the
data was performed with Statview (BrainPower, Inc., Calabasas, Calif.).
Terminal deoxynucleotidyltransferase-mediated dUTP-biotin nick end
labeling (TUNEL) assays were performed with ApopTag fluorescein (Oncor).
Immunoblot analyses.
Cell lysates were prepared as described
earlier (81) in lysis buffer containing 1% Nonidet P-40.
Proteins were separated in 8 or 15% polyacrylamide gels by sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-PAGE) and
transblotted to nitrocellulose. Immunoblot analysis was performed with
the following antibodies: anti-caspase 3 (anti-CPP32; Transduction
Laboratories), anti-caspase 7 (Transduction Laboratories),
anti-PARP (UBI), anti-Rad51, anti-PCNA (Santa Cruz), anti-green
fluorescent protein (anti-GFP; Clontech) or anti-Flag (M2; Eastman Kodak).
Generation of recombinant Rad51 proteins and protease cleavage
assays.
A Rad51 (D184A and D187A) mutant was generated in two
steps by overlapping primer extension and verified by DNA sequencing. Vectors expressing Flag-Rad51, Flag-Rad51(D-A), Flag-Rad51(1-187), or
Flag-Rad51(188-339) were prepared by subcloning PCR-generated HsRad51
into a Flag-tagged pcDNA3 vector. The identity of the subcloned HsRad51
was confirmed by restriction enzyme digestion and DNA sequencing. The
wild-type or mutant Rad51 proteins were expressed in 293 cells and
purified by using anti-Flag immunoaffinity columns. The purified
proteins were incubated with 2.5 µg of purified recombinant
caspase 3 or caspase 7 (70) per ml in 50 mM HEPES (pH 7.5), 10% glycerol, 2.5 mM dithiothreitol, and 0.24 mM EDTA at
room temperature for 30 min. Cleavage reactions were also performed at
37°C for 90 min in the presence of 5 µg of lysate from cells prepared 3 h after IR exposure. The IR-treated cell lysate was depleted of caspase 3 by two rounds of immunoprecipitation with anti-caspase 3 antibody and was reconstituted by the addition of
recombinant caspase 3. The reaction products were analyzed by
electrophoresis (SDS-15% PAGE) transferred to nitrocellulose membranes, and immunoblotted with anti-Rad51 antibody.
DNA binding assays.
Full-length, N-terminal (amino acid 1 to
187), and C-terminal (amino acid 188 to 339) Rad51 proteins were
labeled with [35S]methionine during synthesis in coupled
transcription and translation reactions (Promega, Madison, Wis.). The
labeled proteins were incubated with single-stranded DNA (ssDNA)
cellulose beads for 30 min at 4°C. The beads were extensively washed,
boiled in loading dye, resolved by SDS-PAGE, and analyzed by autoradiography.
Cell transfections.
The wild-type HsRad51 and the
(D-A) mutant of HsRad51 [Rad51(D-A)] were subcloned into the
pEGFP-C1 vector (Clontech). The vectors were transiently transfected
into Rat1/myc or U2-OS cells by the calcium phosphate method. HeLa
cells stably expressing Flag-tagged wild-type Rad51 or the Rad51(D-A)
mutant were prepared by selection in the presence of neomycin.
Homologous recombination assays.
Wild-type, Rad51(D-A)
mutant, N-terminal (positions 1 to 187), or C-terminal (positions 188 to 339) Rad51 proteins were transiently (GFP-tagged) or stably
(Flag-tagged) expressed in FSH cells, and homologous recombination
rates were assayed as described previously (42).
 |
RESULTS |
Rad51 is cleaved during IR-induced apoptosis.
To assess the
temporal effects of IR on the induction of apoptosis, irradiated U-937
cells were monitored for the accumulation of sub-G1 DNA content
(45). There was little effect at 1 h after IR
exposure; however, sub-G1 DNA was apparent by 3 h and exhibited further increases at 5 to 7 h (Fig.
1A). This induction of sub-G1 DNA was
temporally associated with the activation of caspase 3 and
caspase 7. Lysates from irradiated cells exhibited cleavage of the
caspase 3 proenzyme to its active subunits (23, 47) at
3 h, and further activation was detectable at 5 to 7 h (Fig. 1B). Similar findings were obtained for the activation of
caspase 7 (Fig. 1B). In concert with these findings,
caspase-dependent cleavage of PARP (47) exhibited a
similar pattern (Fig. 1B). Significantly, immunoblot analysis of the
lysates with anti-Rad51 demonstrated cleavage of the intact 36-kDa
Rad51 to a 21-kDa fragment (Fig. 1C). Similar patterns of Rad51
cleavage were observed in U-937 cells induced to undergo apoptosis by
exposure to 5 or 10 Gy of IR (data not shown). The IR-induced cleavage
of Rad51 exhibited kinetics similar to those for caspase 3 and
caspase 7 activation and appearance of apoptotic cells with the
sub-G1 DNA content. In contrast, there was no detectable cleavage of
proliferating cell nuclear antigen (PCNA) in IR-induced apoptosis (Fig.
1C). As a control, 35S-labeled Rad51 prepared by in vitro
transcription or translation was added to cells prior to the lysis
procedure. The finding that exogenous [35S]Rad51 is not
cleaved during preparation of the lysate supports specific cleavage of
endogenous Rad51 as part of the apoptotic response (Fig. 1D).

View larger version (32K):
[in this window]
[in a new window]
|
FIG. 1.
Rad51 is cleaved during IR-induced apoptosis. U-937
cells were treated with 20 Gy IR and harvested at the indicated times.
(A) DNA content was assessed by flow cytometry after ethanol-fixed
cells were stained with propidium iodide. (B and C) Cell lysates were
subjected to immunoblot analysis with anti-caspase 3, anti-caspase 7, anti-PARP, anti-Rad51, or anti-PCNA. (D) U-937
cells treated with 20 Gy of IR were harvested at 5 h.
[35S]Rad51 was added to the cells just prior to lysis at
4°C. Input [35S]Rad51 and lysate were analyzed by
SDS-PAGE and autoradiography.
|
|
IR induces Rad51 cleavage by a CrmA-insensitive, p35-sensitive
pathway.
The temporal association between caspase
3/caspase 7 activation and Rad51 proteolysis in irradiated cells
suggested the involvement of a caspase-mediated mechanism in Rad51
cleavage. U-937 cell clones that overexpress CrmA or p35
(17) were assayed to determine whether Rad51 cleavage is
sensitive to inhibitors of caspases. For purposes of comparison,
the cells were treated with TNF or IR. Whereas TNF treatment of U-937
cells stably transfected with the empty vector produced accumulation of
sub-G1 DNA, TNF-induced apoptosis was inhibited in U-937/CrmA and
U-937/p35 cells (Fig. 2A). These findings
confirm that CrmA is functional in the U-937/CrmA cells. In contrast,
while apoptosis induced by IR was insensitive to the expression of
CrmA, the finding that p35 blocks the appearance of sub-G1 DNA in
irradiated cells supports the involvement of caspases. In concert
with these results, CrmA blocked TNF-induced, but not IR-induced,
activation of caspase 3 and proteolytic cleavage of PARP, while p35
inhibited these events in both TNF- and IR-treated cells (Fig. 2B).
Although there was no detectable cleavage of Rad51 in the TNF-treated
cells, IR-induced cleavage of Rad51, like that for PARP, was
insensitive to CrmA and inhibited by p35 expression (Fig. 2B). Of note,
in certain preparations the anti-Rad51 antibody reacts with a protein
that migrates faster than intact Rad51 and is not dependent on
caspase activation. Nonetheless, the results support cleavage of
Rad51 by a caspase-mediated mechanism which is activated during IR-
and not TNF-induced apoptosis.

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 2.
IR induces Rad51 cleavage by a CrmA-insensitive,
p35-sensitive mechanism. U-937 cells stably expressing an empty vector,
CrmA, or p35 were treated with 30 ng of TNF per ml for 6 h or with
20 Gy of IR and then harvested at 7 h. (A) DNA content was
assessed by flow cytometry. (B) Cell lysates were subjected to
immunoblotting analysis with anti-caspase 3, anti-PARP, or
anti-Rad51.
|
|
To provide further support for the involvement of a caspase, cells
were treated with the tetrapeptide aldehydes acetyl-DEVD-CHO
(Ac-DEVD-CHO) and Ac-YVAD-CHO. The peptide component of Ac-DEVD-CHO
is
that found in the S
4-S
1 sites of caspase 3 substrates, and
the aldehyde is a potent inhibitor of this protease. By
contrast,
Ac-YVAD-CHO preferentially inhibits caspase 1 and related
subfamily
members (
48). Preincubation of U-937 cells with
Ac-DEVD-CHO,
and not Ac-YVAD-CHO, inhibited IR-induced accumulation of
sub-G1
DNA content (Fig.
3A). Ac-DEVD-CHO
had little effect on IR-induced
activation of caspase 3 but blocked
cleavage of PARP (Fig.
3B).
Importantly, Ac-DEVD-CHO, but not
Ac-YVAD-CHO, functioned as an
inhibitor of Rad51 cleavage (Fig.
3B).
These findings and those
obtained with the p35 inhibitor suggest that
Rad51 is a substrate
for a caspase sensitive to Ac-DEVD-CHO in
IR-induced apoptosis.

View larger version (19K):
[in this window]
[in a new window]
|
FIG. 3.
Inhibition of IR-induced apoptosis and Rad51 cleavage by
Ac-DEVD-CHO. U-937 cells were preincubated with 100 µM Ac-YVAD-CHO or
Ac-DEVD-CHO for 30 min, treated with 20 Gy of IR, and then harvested at
7 h. (A) DNA content was assessed by flow cytometry. (B) Cell
lysates were subjected to immunoblot analysis with anti-caspase 3, anti-PARP, or anti-Rad51.
|
|
Rad51 is cleaved by caspase 3 in vitro.
As deduced from
synthetic peptide substrates, caspase 3 and caspase 7 exhibit
an S4-S1 subsite preference with a DXXD
consensus (70, 72). A DVLD/N site is present in mouse and
human Rad51 at amino acids 184 to 188 (60). To determine
whether Rad51 is cleaved by caspase 3, Flag-tagged Rad51 was
expressed in 293 cells and purified by using immunoaffinity columns.
The purified Flag-tagged Rad51 was incubated with recombinant
caspase 3, and the products were subjected to immunoblotting
with anti-Rad51 antibody. Caspase 3 cleaved Rad51 to a 21-kDa
fragment (Fig. 4A). Similar results were
obtained when the purified Flag-Rad51 was incubated with lysates from
IR-treated U-937 cells that exhibit activation of caspase 3 (Fig. 4A). The 21-kDa cleavage fragment of Rad51 exhibited an
electrophoretic mobility similar to that of a recombinant
N-terminal fragment of Rad51 that extends to the DVLD187
site (Fig. 4A). Whereas these findings provided support for
caspase-3-mediated cleavage of Rad51 at the DVLD/N site,
we generated a Rad51 protein with the S4 to S1
aspartic acids mutated to alanines (AVLA/N). Compared to
wild-type Rad51, the Rad51(D-A) mutant was more resistant to cleavage
by recombinant caspase 3 and lysates from IR-induced apoptotic
U-937 cells (Fig. 4B). To confirm the involvement of caspase 3, we
depleted caspase 3 from the U-937 cell lysate with an
anti-caspase 3 antibody. The findings that the immunodepleted lysate fails to cleave wild-type Rad51 and that reconstitution with
recombinant caspase 3 restores the activity provided additional support for a caspase 3-mediated mechanism of Rad51 cleavage
(Fig. 4B). Moreover, resistance of the Rad51(D-A) mutant to
cleavage by caspase 3 and by lysates from TNF-treated cells (Fig.
4C) confirms the involvement of the DVLD/N site. To determine
whether Rad51 is cleaved by other executioner caspases, we
incubated purified Rad51 with recombinant caspase 7. The results
demonstrate that caspase 7 cleaves Rad51 and not Rad51(D-A)
(Fig. 4D). These findings demonstrate that caspase 7, like
caspase 3, cleaves Rad51 at the DVLD/N site in vitro. Thus,
to assess the role of caspase 3 and/or caspase 7 in the
cleavage of Rad51 in vivo, studies were performed on MCF-7 cells that
are caspase 3 deficient (28). IR treatment of MCF-7
cells was associated with activation of caspase 7 and the cleavage
of PARP (Fig. 5). In contrast, there was
no detectable cleavage of Rad51 (Fig. 5). These results provide support
for the cleavage of Rad51 by caspase 3, and not caspase 7, in
irradiated cells. The discrepancy between the cleavage of Rad51 by
caspase 7 in vitro, but not in irradiated cells, may be related to
subcellular localization of caspase 7 to the mitochondria and
endoplasmic reticulum (12).

View larger version (34K):
[in this window]
[in a new window]
|
FIG. 4.
Recombinant Rad51 is cleaved at a DVLD/N site by
caspase 3 in vitro. (A) Flag-tagged Rad51 was overexpressed in 293 cells and purified by immunoaffinity column. The purified Rad51 was
incubated with recombinant caspase 3 (2.5 µg/ml) for 30 min at
room temperature or lysate from U-937 cells treated with 20 Gy of IR
and harvested at 3 h. The reaction products were subjected to
immunoblotting with anti-Rad51. The recombinant N-terminal
Rad51(1-187) fragment was purified from 293 cells and included as a
control. The small amount of full-length Rad51 in this lane is a
contaminant present after partial purification of the recombinant
Rad51(1-187) from 293 cell lysates. (B) Flag-tagged wild-type Rad51
and the DVLD/N-to-AVLA/N mutant, designated (D-A), were overexpressed
in 293 cells and purified by using an immunoaffinity column. Purified
Rad51 and the Rad51(D-A) mutant were incubated with recombinant
caspase 3 and lysates from IR-treated U-937 cells. The cell lysate
was depleted of caspase 3 by two immunoprecipitations with
anti-caspase 3 [lysate ( )]. Reconstitution of this lysate was
achieved by the addition of 2.5 µg of recombinant caspase 3 per
ml [lysate (+)]. The reaction products were analyzed by
immunoblotting with anti-Rad51. (C) Purified Rad51 was incubated with
lysates from control (lane 1) and TNF-treated (lane 3; 30 ng/ml for
6 h) U-937 cells. Purified Rad51(D-A) was incubated with lysate
from TNF-treated cells (lane 2). The reaction products were analyzed by
immunoblotting with anti-Rad51. The recombinant Rad51(1-187) fragment
was included as a control (lane 4). (D) Purified Rad51 and the
Rad51(D-A) mutant were incubated with recombinant caspase 7. The
reaction products were analyzed by immunoblotting with anti-Rad51.
|
|

View larger version (23K):
[in this window]
[in a new window]
|
FIG. 5.
IR-induced cleavage of Rad51 is abrogated in caspase
3-deficient MCF-7 cells. Lysates were prepared from control (C) MCF-7
cells and, at the indicated times after exposure to 20 Gy of IR, were
subjected to immunoblot analysis with anti-caspase 7, anti-PARP, or
anti-Rad51.
|
|
Rad51 is cleaved at the DVLD/N site in vivo.
To determine
whether Rad51 is cleaved at the DVLD/N site in cells induced to undergo
apoptosis, we stably expressed wild-type Rad51 and the Rad51(D-A)
mutant in HeLa cells. Immunoblot analysis of the transfectants
demonstrated increased reactivity with anti-Rad51 antibody compared to
cells transfected with the empty vector (Fig. 6, upper panel). Irradiation of cells
expressing the empty vector resulted in the cleavage of Rad51 and the
activation of caspase 3 (Fig. 6, upper panel). Similar findings
were obtained in cells overexpressing the wild-type Rad51 protein (Fig.
6, upper panel). In contrast and in concert with the in vitro findings,
there was no detectable cleavage of the Rad51(D-A) mutant (Fig. 6,
upper panel). The activation of caspase 3, however, was
comparable in HeLa cells expressing the empty vector, wild-type Rad51,
or Rad51(D-A) (Fig. 6, lower panel). These results demonstrate that
Rad51 is cleaved at the DVLD/N site in irradiated cells.

View larger version (45K):
[in this window]
[in a new window]
|
FIG. 6.
Rad51 is cleaved at the DVLD/N site in vivo. Wild-type
Rad51 and the Rad51(D-A) mutant were stably expressed in HeLa
cells. Control HeLa cells expressed the empty vector. The HeLa cell
transfectants were treated with 20 Gy of IR and harvested at the
indicated times. Cell lysates were subjected to immunoblotting with
anti-Rad51 or anti-caspase 3.
|
|
Functional role of Rad51 cleavage.
Rad51 binds ssDNA to form
nucleoprotein filaments that undergo pairing with duplex DNA (6,
68). To assess the effects of cleavage on the binding of Rad51 to
ssDNA, we prepared N- and C-terminal fragments that correspond to those
generated by cleavage at the DVLD/N site (Fig.
7A). As shown previously (6,
49), full-length Rad51 binds to ssDNA (Fig. 7A). Similar results
were obtained with the N-terminal Rad51(1-187) and C-terminal
Rad51(188-339) fragments (Fig. 7A). In contrast, there was no
detectable binding of these proteins to cellulose beads devoid of ssDNA
(data not shown). Whereas it is unlikely that proteins from the
reticulocyte lysate contribute to the binding of the Rad51 fragments,
these findings suggest that the cleavage of Rad51 at the DVLD/N site has little if any effect on the direct binding of Rad51 to ssDNA. To
assess the effects of cleavage of Rad51 recombinase activity, we
assayed the homologous recombination between lacZ
chromosomal direct repeats in FSH cells (42). Transient
expression of both wild-type Rad51 and the Rad51(D-A) mutant tagged
with GFP (Fig. 7B, left panel) stimulated greater
recombination compared to that obtained with transfection of the empty
vector (Fig. 7B, right panel). In contrast, there was little if any
stimulation of homologous recombination as a result of transiently
expressing the GFP-tagged Rad51(1-187) or Rad51(188-339)
fragments (Fig. 7B). To confirm the effects of cleavage on Rad51
recombinase activity, FSH cells were stably transfected with
Flag-tagged Rad51, the Rad51(D-A) mutant, or the Rad51 fragments.
Immunoblot analysis of the transfectants with anti-Flag antibody
confirmed the overexpression of the Rad51 proteins (Fig. 7C, left
panel). As shown in the transient-transfection studies, recombination
was stimulated by wild-type Rad51 and the Rad51(D-A) mutant but
not by the N- or C-terminal fragments (Fig. 7C, right panel).
These findings indicate that cleavage of Rad51 by caspase 3 results
in the abrogation of Rad51 recombinase activity.


View larger version (47K):
[in this window]
[in a new window]
|
FIG. 7.
Cleavage of Rad51 at the DVLD/N site abrogates Rad51
function in homologous recombination. (A) Full-length Rad51, the
N-terminal Rad51(1-187) fragment and the C-terminal
Rad51(188-339) fragment were synthesized by in vitro transcription
and translation in the presence of [35S]methionine. The
products were incubated with ssDNA-conjugated cellulose beads for 30 min. The beads were extensively washed and boiled in loading dye. Input
proteins (not bound to ssDNA) and proteins eluted from the
ssDNA-conjugated cellulose beads were subjected to SDS-PAGE and
autoradiography. (B) GFP-tagged Rad51 (full length), Rad51(D-A),
Rad51(1-187) and Rad51(188-339) were transiently
overexpressed in FSH cells for 72 h. The transfectants were
subjected to immunoblot analysis with anti-GFP (left panel). Homologous
recombination was assessed by determining the -galactosidase
activity of GFP-positive cells. Results are expressed as the fold
increase (mean ± the standard deviation [SD] of three
experiments, each performed in duplicate) in recombination compared to
that obtained in the FSH cells expressing the GFP-empty vectors (right
panel). (C) FSH cells were stably transfected to express Flag (vector),
Flag-tagged Rad51, Flag-tagged Rad51(D-A), Flag-tagged
Rad51(1-187), or Flag-tagged Rad51(188-339). Transfectants
were subjected to immunoblot analysis with anti-Flag (left panel). The
fold increase in recombination was assessed by comparing the
-galactosidase activity to that obtained in the FSH cells expressing
the Flag-empty vector. The results are expressed as the mean ± the SD of three determinations, each performed in duplicate (right
panel).
|
|
Involvement of Rad51 cleavage in apoptosis.
Whereas cells
deficient in Rad51 exhibit an increased sensitivity to IR
(69), we asked whether the cleavage of Rad51 has a
functional role in the induction of apoptosis. Rat1/myc cells were
transiently transfected with GFP vectors expressing wild-type or mutant
Rad51. After 24 h, the transfected cells were exposed to IR and
incubated for an additional 72 h, and the GFP-positive cells
were analyzed for sub-G1 DNA content. Compared to cells transfected with the empty vector, the overexpression of
wild-type Rad51 partially inhibited the induction of apoptosis (Fig.
8A). Importantly, overexpression of the
Rad51(D-A) mutant was more effective than wild-type Rad51 in
protecting Rat1/myc cells against IR-induced apoptosis (Fig. 8A).
Similar results were obtained with U2-OS cells transiently transfected
with Rad51 or Rad51(D-A) and treated with IR (Fig. 8B). These
findings indicate that the protective effects of Rad51(D-A) against
IR-induced apoptosis are not cell type specific.

View larger version (21K):
[in this window]
[in a new window]
|
FIG. 8.
Transient overexpression of the Rad51(D-A) mutant
confers resistance to IR-induced apoptosis of Rat1/myc and U2-OS cells.
GFP-tagged wild-type Rad51 or the Rad51(D-A) mutant were
transiently transfected into Rat1/myc (A) and U2-OS (B) cells. As
controls, cells were transfected with the GFP-expressing empty vector.
The cells were treated with 20 Gy of IR at 24 h posttransfection
and then incubated for an additional 72 h. The GFP-positive cells
were sorted and analyzed for DNA content by flow cytometry (upper
panels) or for GFP-tagged Rad51 by immunoblotting with anti-GFP (lower
panel). The flow cytometery results are expressed as the percentage
(mean ± the standard deviation from two independent experiments,
each performed in triplicate) of cells with sub-G1 DNA content. Cells
were transfected with the empty vector (solid bars), wild-type Rad51
(diagonal lined bar), or the Rad51(D-A) mutant (horizontal lined
bar).
|
|
Other studies were performed with HeLa cell clones that stably express
the Flag-tagged wild-type or mutant Rad51 (Fig.
9A).
Assessment of IR-induced apoptosis
demonstrated that, whereas
wild-type Rad51 inhibited the
response, mutant Rad51(D-A) was
more effective in blocking
the appearance of cells positive for
sub-G1 DNA content (Fig.
9B). In
contrast, overexpression of Rad51
or Rad51(D-A) had no apparent
effect on the extent of apoptosis
induced by exposure to TNF (Fig.
9C).
To confirm these findings,
the HeLa cell transfectants were
exposed to IR and then assayed
for TUNEL staining. The results
demonstrate that, as shown for
the induction of sub-G1 DNA,
overexpression of Rad51 and, in particular,
the Rad51(D-A) mutant
decreased the percentage of cells that exhibit
TUNEL positivity
(Fig.
10A). Whereas HeLa cells
overexpressing
Rad51 failed to exhibit defects in the cleavage of
procaspase
3 by IR exposure (Fig.
6), caspase-3-mediated
cleavage of PARP
was assessed to confirm the activation of caspase
3. The results
demonstrate that overexpression of wild-type
Rad51 or the Rad51(D-A)
mutant has little if any effect on
IR-induced PARP cleavage (Fig.
10B). These findings demonstrate
that overexpression of wild-type
Rad51 and particularly the
Rad51(D-A) mutant confers resistance
to DNA fragmentation, and not
caspase 3 activation, associated
with the induction of apoptosis by
IR exposure.

View larger version (28K):
[in this window]
[in a new window]
|
FIG. 9.
Stable expression of the Rad51(D-A) mutant confers
resistance to IR-induced apoptosis of HeLa cells. HeLa cells were
stably transfected to express the Flag-empty vector (solid bars),
Flag-tagged Rad51 (diagonal lined bars), or Flag-tagged Rad51(D-A)
(horizontal lined bars). (A) Clones (a and b) selected from each of two
independent transfections were subjected to immunoblot analysis with
anti-Flag. The transfectants were treated with 20 Gy of IR and
harvested at the indicated times (B) or were treated with TNF for
12 h (C). The cells were analyzed for DNA content by flow
cytometry. The results are expressed as the percentage (mean ± standard deviation from three separate experiments) of cells with
sub-G1 DNA content.
|
|


View larger version (102K):
[in this window]
[in a new window]
|
FIG. 10.
Expression of Rad51 confers resistance to IR-induced
DNA degradation and not caspase 3 activation. (A) HeLa cells stably
expressing Flag-empty vector, Flag-tagged Rad51, or Flag-tagged
Rad51(D-A) were exposed to 20 Gy of IR, fixed at 48 or 72 h,
and subjected to TUNEL staining. (B) The HeLa cell transfectants were
exposed to 20 Gy of IR and harvested at the indicated times. Cell
lysates were subjected to immunoblotting with anti-PARP.
|
|
 |
DISCUSSION |
Functional significance of caspase-mediated proteolysis to
apoptosis.
Members of the caspase family of cysteine proteases
have been identified as key effectors responsible for the cleavage of proteins during the induction of apoptosis. Certain proteins
inactivated as a result of caspase cleavage, such as DNA-PK and
the retinoblastoma tumor suppressor, are not essential for cell
viability. PARP, a protein involved in DNA repair and the suppression
of an apoptotic endonuclease (39), is also cleaved during
apoptosis (29, 36); however, the significance of this event
is uncertain, since PARP-deficient cells exhibit an intact apoptotic
response to DNA-damaging agents (75). Substrates that are
activated as a consequence of caspase-induced cleavage include
protein kinase C
(PKC
) (19, 20), PKC
(18), p21-activated kinase 2 (PAK2) (58),
cytosolic phospholipase A2 (76), sterol regulatory binding
proteins (51), the 45-kDa subunit of DNA fragmentation
factor (40), and PITSLRE kinase
2-1 (7).
Although expression of the cleaved fragments of PKC
, PKC
, or PAK2
induces certain characteristics of apoptosis (18, 25, 58),
the available evidence is insufficient to assess the role of these
activated products in cell death. Conversely, certain substrates that
exhibit functional roles for caspase-mediated cleavage in the
apoptotic response have been identified. A caspase-activated DNase
that degrades DNA during apoptosis has recently been identified (22). Other work has shown that caspase-mediated
cleavage of nuclear lamin and the actin regulatory protein gelsolin
contributes to changes characteristic of apoptosis (34, 50,
56). Collectively, these findings have thus resulted in the
identification of diverse proteins that are activated or inactivated by
caspases and thereby contribute to the apoptotic program.
Rad51 is cleaved by a member of the caspase family.
The
present results support cleavage of Rad51 by a
caspase-mediated mechanism in IR-induced apoptosis. In
this regard, Rad51 cleavage in irradiated cells is blocked by
expression of the baculovirus p35 protein. p35 inhibits caspases 1, 2, 3, and 4 in vitro (9, 77) and blocks apoptosis induced by
DNA-damaging agents (16) and diverse other stimuli
(74). In contrast to p35, CrmA inhibits caspases 1 and 8 at nM concentrations in vitro (82) and blocks TNF-induced,
but not DNA damage-induced, apoptosis (16, 17). In concert
with these findings, CrmA had no effect on cleavage of Rad51 in
irradiated cells.
The present findings also demonstrate that Rad51 is cleaved at a DVLD/N
site by caspase 3 in vitro. Mutation of the aspartic
acid
residues to alanines (AVLA/N) blocked caspase-3-mediated
cleavage
of Rad51 in vitro. The finding that expression of the
Rad51(D-A)
mutant in cells also blocks IR-induced cleavage provided
support for
the physiologic importance of the DVLD/N site. After
completion of
these studies, other work which demonstrates that
Rad51 is cleaved
during the apoptosis of T lymphocytes was published
(
24). In
contrast to our results, the Rad51 cleavage site was
not mapped and
Rad51 was not cleaved by caspase 3 (
24). Thus,
Rad51 may
be subject to cleavage by different mechanisms. Whereas
caspases 2, 3, and 7 cleave at DXXD sites (
70,
72), any of
these
proteases may be responsible for cleavage of Rad51 in cells.
For
example, PARP cleavage has been attributed to caspase 3 in
in vitro
studies (
29,
36), yet cells deficient in caspase
3 effectively cleave PARP during the induction of apoptosis
(
35).
In contrast, the finding that Rad51 is not cleaved in
caspase
3-deficient MCF-7 cells after IR treatment provides support
for
a caspase 3-dependent mechanism. Of interest is the present
finding
that Rad51 is not cleaved during TNF-induced apoptosis,
yet lysates
from TNF-treated cells mediate Rad51 cleavage.
Whereas caspase
3 is activated by both TNF and IR treatment,
cleavage of Rad51
may be dependent on a posttranslational modification
that occurs
during DNA damage-induced signaling and results in the
subcellular
accessibility of Rad51 to caspase 3-mediated
proteolysis. In this
context, recent studies have demonstrated that
Rad51 is phosphorylated
in IR-treated cells by the proapoptotic c-Abl
tyrosine kinase
and that c-Abl-mediated phosphorylation of Rad51
abrogates the
binding of Rad51 to DNA (
80).
Role for Rad51 in cell survival.
RecA in E. coli
and ScRad51 in S. cerevisiae are essential for
recombinational DNA repair. In yeast cells, rad51 mutants are sensitive
to IR and defective in DNA damage-induced mitotic recombination (61). Also, ScRad51 expression is induced in response to IR and other DNA-damaging agents (1, 3, 61). Whereas yeast cells deficient in Rad51 are viable, disruption of the rad51
gene in mice results in an early arrest of embryonic development
(38, 73). These findings indicate that Rad51 performs an
essential function in mammalian and not in yeast cells, yet both
rad51
/
cell types are defective in cell proliferation,
exhibit increased radiosensitivity, and display chromosome loss
(38, 44, 73). Antisense inhibition of Rad51 expression in
mouse cells has confirmed an essential role for this protein in cell
proliferation and in the repair of IR-induced DNA lesions
(69). Other studies in Rad51
/
chicken cells
expressing a human Rad51 transgene confirm a role for Rad51 in the
repair of chromosome breaks that accumulate during proliferation
(64). Mammalian Rad51 binds to ssDNA and thereby promotes
homologous pairing and strand exchange in vitro (4). The
present studies demonstrate that cleavage of Rad51 at the DVLD/N site
generates N- and C-terminal fragments that retain binding to ssDNA.
However, in a cell-based model of homologous recombination, the results
demonstrate that cleavage at the DVLD/N site abrogates the Rad51
recombinase activity. Taken together, these findings support a model in
which caspase-mediated cleavage of Rad51 in irradiated cells
inhibits Rad51 activity and thereby recombinational repair. Proteolytic
cleavage of Rad51 in the induction of apoptosis could also affect an
essential function of Rad51 that involves interactions with other
proteins such as p53 (65) or BRCA1 (59).
Caspase-mediated cleavage of Rad51 is a function of the apoptotic
response.
The present results further demonstrate that transient
overexpression of wild-type Rad51 and particularly the Rad51(D-A)
mutant inhibits IR-induced apoptosis. These findings could be explained by the requirement of a critical level of Rad51 that is essential for
recombinational repair of IR-induced DNA double-strand breaks and/or
cell survival. In this context, our findings demonstrate that cells
overexpressing Rad51 exhibit increased levels of recombinational activity. While it is perhaps unexpected that the level of homologous recombination is stimulated by overexpression of only Rad51, other studies have shown that mammalian cells overexpressing Rad52 exhibit increased homologous recombination and double-stranded DNA break repair
(53). Taken together with our results and more recent studies demonstrating that Rad52 stimulates the function of Rad51 (5, 46, 63, 66), these findings suggest that overexpression of either component, i.e., Rad51 or Rad52, stimulates the level of
homologous recombination and thereby the repair of IR-induced lesions.
Alternatively, the present results do not exclude the possibility that
overexpression of Rad51 interferes with DNA metabolism and results in
DNA lesions that are repaired by recombination. In addition, given
findings that Rad51 functions as a polymer in recombinational repair,
our results do not exclude the potential for Rad51 cleavage products to
be functionally active in the context of a mixed polymer with intact
Rad51 that persists after IR treatment.
Activation of caspase 3 was similar in cells expressing wild-type
or mutant Rad51 compared to those expressing the empty vector.
These
findings indicate that the caspase pathway is activated
in response
to IR-induced DNA damage in cells transfected to express
wild-type or
mutant Rad51. The demonstration that these cells
also respond
appropriately to IR with activation of c-Abl and
the SAPK pathway (data
not shown) supports an intact response
to the DNA lesions induced by IR
exposure. Moreover, the results
suggest that cleavage of Rad51
and thereby inactivation of this
protein may be involved in the cell
death response. Compared to
control cells, the transfectants expressing
the wild-type protein
exhibit increased levels of Rad51. If
inactivation of Rad51 by
proteolysis contributes to apoptotic cell
death, then increased
levels should be protective. Studies with the
caspase-resistant
Rad51 mutant support this hypothesis. Cells that
express Rad51(D-A)
were significantly more resistant to IR-induced
apoptosis than
cells that overexpress wild-type Rad51. Notably,
overexpression
of Rad51 or Rad51(D-A) could protect cells against
apoptosis by
the titration of caspases and/or other effectors of
the cell death
response. Thus, one could argue that Rad51 has little if
any effect
on apoptosis under physiological conditions. Nonetheless,
the
essential role for Rad51 in cell survival suggests that proteolytic
inactivation of Rad51 could contribute in part to the induction
of
apoptosis.
 |
ACKNOWLEDGMENTS |
This investigation was supported by Public Health Service grant
CA55241 awarded by the National Cancer Institute.
We thank Akira Shinohara for the anti-human Rad51 antibody and the
human Rad51 cDNA and James Stringer for the FSH cells.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Dana-Farber
Cancer Institute, Harvard Medical School, 44 Binney St., Boston,
MA 02115. Phone: (617) 632-3141. Fax: (617) 632-2934. E-mail:
donald_kufe{at}dfci.harvard.edu.
 |
REFERENCES |
| 1.
|
Aboussekhra, A.,
R. Chanet,
A. Adjiri, and F. Fabre.
1992.
Semi-dominant suppressors of srs2 helicase mutations of Saccharomyces cerevisiae map in the RAD51 gene, whose sequence predicts a protein with similarities to prokaryotic RecA proteins.
Mol. Cell. Biol.
12:3224-3234[Abstract/Free Full Text].
|
| 2.
|
Armstrong, R. C.,
T. Aja,
J. Xiang,
S. Gaur,
J. F. Krebs,
K. Hoang,
X. Bai,
S. J. Korsmeyer,
D. S. Karanewsky,
L. C. Fritz, and K. J. Tomaselli.
1996.
Fas-induced activation of the cell death-related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors.
J. Biol. Chem.
271:16850-16855[Abstract/Free Full Text].
|
| 3.
|
Basile, G.,
M. Aker, and R. K. Mortimer.
1992.
Nucleotide-sequence and transcriptional regulation of the yeast recombinational repair gene RAD51.
Mol. Cell. Biol.
12:3235-3246[Abstract/Free Full Text].
|
| 4.
|
Baumann, P.,
F. E. Benson, and S. C. West.
1996.
Human Rad51 protein promotes ATP-dependent homologous pairing and strand transfer reactions in vitro.
Cell
87:757-766[Medline].
|
| 5.
|
Benson, F. E.,
P. Baumann, and S. C. West.
1998.
Synergistic actions of Rad51 and Rad52 in recombination and DNA repair.
Nature
391:401-404[Medline].
|
| 6.
|
Benson, F. E.,
A. Stasiak, and S. C. West.
1994.
Purification and characterisation of the human Rad51 protein, an analogue of E. coli RecA.
EMBO J.
13:5764-5771[Medline].
|
| 7.
|
Beyaert, R.,
V. J. Kidd,
S. Cornelis,
M. Van de Craen,
G. Denecker,
J. M. Lahti,
R. Gururajan,
P. Vandenabeele, and W. Fiers.
1997.
Cleavage of PITSLRE kinases by ICE/CASP-1 and CPP32/CASP-3 during apoptosis induced by tumor necrosis factor.
J. Biol. Chem.
272:11694-11697[Abstract/Free Full Text].
|
| 8.
|
Bishop, D. K.,
D. Park,
L. Z. Xu, and N. Keckner.
1992.
DMC1: a meiosis-specific yeast homolog of E. coli RecA required for recombination, synaptonemal complex formation, and cell cycle progression.
Cell
69:439-456[Medline].
|
| 9.
|
Bump, N. J.,
M. Hackett,
M. Hugunin,
S. Seshagiri,
K. Brady,
P. Chen,
C. Ferenz,
S. Franklin,
T. Ghayur,
P. Li,
P. Licari,
J. Mankovich,
L. Shi,
A. H. Greenberg,
L. K. Miller, and W. W. Wong.
1995.
Inhibition of ICE family proteases by baculovirus antiapoptotic protein p35.
Science
269:1885-1888[Abstract/Free Full Text].
|
| 10.
|
Cartier, J. L.,
P. A. Hershberger, and P. D. Friesen.
1994.
Suppression of apoptosis in insect cells stably transfected with baculovirus p35: dominant interference by N-terminal sequences p35(1-76).
J. Virol.
68:7728-7737[Abstract/Free Full Text].
|
| 11.
|
Casciola-Rosen, L.,
D. W. Nicholson,
T. Chong,
K. R. Rowan,
N. A. Thornberry,
D. K. Miller, and A. Rosen.
1996.
Apopain/CPP32 cleaves proteins that are essential for cellular repair: a fundamental principle of apoptotic death.
J. Exp. Med.
183:1957-1964[Abstract/Free Full Text].
|
| 12.
|
Chandler, J. M.,
G. M. Cohen, and M. MacFarlane.
1998.
Different subcellular distribution of caspase-3 and caspase-7 following Fas-induced apoptosis in mouse liver.
J. Biol. Chem.
273:10815-10818[Abstract/Free Full Text].
|
| 13.
|
Chauhan, D.,
P. Pandey,
A. Ogata,
G. Teoh,
N. Krett,
R. Halgren,
S. Rosen,
D. Kufe,
S. Kharbanda, and K. Anderson.
1997.
Cytochrome-C dependent and independent induction of apoptosis in multiple myeloma cells.
J. Biol. Chem.
272:29995-29997[Abstract/Free Full Text].
|
| 14.
|
Clem, R. J.,
M. Fechheimer, and L. K. Miller.
1991.
Prevention of apoptosis by a baculovirus gene during infection of insect cells.
Science
254:1388-1390[Abstract/Free Full Text].
|
| 15.
|
Clem, R. J., and L. K. Miller.
1994.
Control of programmed cell death by the baculovirus genes p35 and iap.
Mol. Cell. Biol.
14:5212-5222[Abstract/Free Full Text].
|
| 16.
|
Datta, R.,
D. Banach,
H. Kojima,
R. V. Talanian,
E. S. Alnemri,
W. W. Wong, and D. Kufe.
1996.
Activation of the CPP32 protease in apoptosis induced by 1- -D-arabinofuranosylcytosine and other DNA damaging agents.
Blood
88:1936-1943[Abstract/Free Full Text].
|
| 17.
|
Datta, R.,
H. Kojima,
D. Banach,
N. J. Bump,
R. V. Talanian,
E. S. Alnemri,
R. R. Weichselbaum,
W. W. Wong, and D. W. Kufe.
1997.
Activation of a CrmA-insensitive, p35-sensitive, pathway in ionizing radiation-induced apoptosis.
J. Biol. Chem.
272:1965-1969[Abstract/Free Full Text].
|
| 18.
|
Datta, R.,
H. Kojima,
K. Yoshida, and D. Kufe.
1997.
Caspase-3 mediated cleavage of protein kinase C in induction of apoptosis.
J. Biol. Chem.
272:20317-20320[Abstract/Free Full Text].
|
| 19.
|
Emoto, Y.,
H. Kisaki,
Y. Manome,
S. Kharbanda, and D. Kufe.
1996.
Activation of protein kinase C in human myeloid leukemia cells treated with 1- -D-arabinofuranosylcytosine.
Blood
87:1990-1996[Abstract/Free Full Text].
|
| 20.
|
Emoto, Y.,
G. Manome,
G. Meinhardt,
H. Kisaki,
S. Kharbanda,
M. Robertson,
T. Ghayur,
W. W. Wong,
R. Kamen,
R. Weichselbaum, and D. Kufe.
1995.
Proteolytic activation of protein kinase C by an ICE-like protease in apoptotic cells.
EMBO J.
14:6148-6156[Medline].
|
| 21.
|
Enari, M.,
H. Hug, and S. Nagata.
1995.
Involvement of an ICE-like protease in Fas-mediated apoptosis.
Nature
375:78-81[Medline].
|
| 22.
|
Enari, M.,
H. Sakahira,
H. Yokoyama,
K. Okawa,
A. Iwanatsu, and S. Natata.
1998.
A caspase-activated DNase that degrades DNA during apoptosis, and its inhibitor ICAD.
Nature
391:43-50[Medline].
|
| 23.
|
Fernandes-Alnemri, T.,
G. Litwack, and E. S. Alnemri.
1994.
CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme.
J. Biol. Chem.
269:30761-30764[Abstract/Free Full Text].
|
| 24.
|
Flygare, J.,
R. C. Armstrong,
A. Wennborg,
S. Orsan, and D. Hellgren.
1998.
Proteolytic cleavage of HsRad51 during apoptosis.
FEBS Lett.
427:247-251[Medline].
|
| 25.
|
Ghayur, T.,
M. Hugunin,
R. V. Talanian,
S. Ratnofsky,
C. Quinlan,
Y. Emoto,
P. Pandey,
R. Datta,
S. Kharbanda,
H. Allen,
R. Kamen,
W. Wong, and D. Kufe.
1996.
Proteolytic activation of protein kinase C by an ICE/CED 3-like protease induces characteristics of apoptosis.
J. Exp. Med.
184:2399-2404[Abstract/Free Full Text].
|
| 26.
|
Gupta, R. C.,
L. R. Bazemore,
E. I. Golub, and C. M. Radding.
1997.
Activities of human recombination protein Rad51.
Proc. Natl. Acad. Sci. USA
94:463-468[Abstract/Free Full Text].
|
| 27.
| Hall, E. J. (ed.). Radiobiology for the
radiologist, p. 17-38. Lippincott, Philadelphia, Pa.
|
| 28.
|
Janicke, R. U.,
M. L. Sprengart,
M. R. Wati, and A. G. Porter.
1998.
Caspase-3 is required for DNA fragmentation and morphological changes associated with apoptosis.
J. Biol. Chem.
273:9357-9360[Abstract/Free Full Text].
|
| 29.
|
Kaufmann, S. H.,
S. Desnoyers,
Y. Ottaviano,
N. E. Davidson, and G. G. Poirier.
1993.
Specific proteolytic cleavage of poly(ADP-ribose) polymerase: an early marker of chemotherapy-induced apoptosis.
Cancer Res.
53:3976-3985[Abstract/Free Full Text].
|
| 30.
|
Kharbanda, S.,
P. Pandey,
L. Schofield,
R. Roncinske,
A. Bharti,
Z.-M. Yuan,
R. Weichselbaum,
C. Nalin, and D. Kufe.
1997.
Role for Bcl-xL as an inhibitor of cytosolic cytochrome C accumulation in apoptosis.
Proc. Natl. Acad. Sci. USA
94:6939-6942[Abstract/Free Full Text].
|
| 31.
|
Kharbanda, S.,
R. Ren,
P. Pandey,
T. D. Shafman,
S. M. Feller,
R. R. Weichselbaum, and D. W. Kufe.
1995.
Activation of the c-Abl tyrosine kinase in the stress response to DNA-damaging agents.
Nature
376:785-788[Medline].
|
| 32.
|
Kim, C. N.,
X. Wang,
Y. Huang,
A. M. Ibrado,
L. Liu,
G. Fang, and K. Bhalla.
1997.
Overexpression of Bcl-xL inhibits araC-induced mitochondrial loss of cytochrome c and other perturbations that activate the molecular cascade of apoptosis.
Cancer Res.
57:3115-3120[Abstract/Free Full Text].
|
| 33.
|
Kluck, R. M.,
E. Bossy-Wetzel,
D. R. Green, and D. D. Newmeyer.
1997.
The release of cytochrome c from mitochondria: a primary site for Bcl-2 regulation of apoptosis.
Science
275:1132-1136[Abstract/Free Full Text].
|
| 34.
|
Kothakota, S.,
T. Azuma,
C. Reinhard,
A. Klippel,
J. Tang,
K. Chu,
T. J. McGarry,
M. W. Kirschner,
K. Koths,
D. J. Kwiatkowski, and L. T. Williams.
1997.
Caspase-3-generated fragment of gelsolin: effector of morphological change in apoptosis.
Science
278:294-298[Abstract/Free Full Text].
|
| 35.
|
Kuida, K.,
T. S. Zheng,
S. Na,
C. Kuan,
D. Yang,
H. Karasuyama,
P. Rakic, and R. A. Flavell.
1996.
Decreased apoptosis in the brain and premature lethality in CPP32-deficient mice.
Nature
384:368-372[Medline].
|
| 36.
|
Lazebnik, Y. A.,
S. H. Kaufmann,
S. Desnoyers,
G. G. Poirier, and W. C. Earnshaw.
1994.
Cleavage of poly(ADP-ribose) polymerase by a proteinase with properties like ICE.
Nature
371:346-347[Medline].
|
| 37.
|
Li, P.,
D. Nijhawan,
I. Budihardjo,
S. M. Srinivasula,
M. Ahmad,
E. S. Alnemri, and X. Wang.
1997.
Cytochrome c and dATP-dependent formation of Apaf-1/caspase-9 complex initiates an apoptotic protease cascade.
Cell
91:479-489[Medline].
|
| 38.
|
Lim, D. S., and P. Hasty.
1996.
A mutation in mouse rad51 results in an early embryonic lethal that is suppressed by a mutation in p53.
Mol. Cell. Biol.
16:7133-7143[Abstract].
|
| 39.
|
Lindahl, T.,
M. S. Satoh,
G. G. Poirier, and A. Klungland.
1995.
Post-translational modification of poly(ADP-ribose) polymerase induced by DNA strand breaks.
Trends Biochem. Sci.
20:405-411[Medline].
|
| 40.
|
Liu, X.,
H. Zou,
C. Slaughter, and X. Wang.
1997.
DFF, a heterodimeric protein that functions downstream of caspase-3 to trigger DNA fragmentation during apoptosis.
Cell
89:175-184[Medline].
|
| 41.
|
Los, M.,
M. van de Craen,
L. C. Penning,
H. Schenk,
M. Westendorp,
P. A. Baeuerle,
W. Droge,
P. H. Krammer,
W. Fiers, and K. Schulze-Osthoff.
1995.
Requirement of an ICE-CED-3 protease for Fas/APO-1-mediated apoptosis.
Nature
375:81-83[Medline].
|
| 42.
|
Ludwig, D. L., and J. R. Stringer.
1994.
Spontaneous and induced homologous recombination between lacZ chromosomal direct repeats in CV-1 cells.
Somat. Cell Mol. Genet.
20:11-25[Medline].
|
| 43.
|
Maeshima, K.,
K. Morimatsu,
A. Shinohara, and T. Horii.
1995.
Rad51 homologs in Xenopus laevis: two distinct genes are highly expressed in ovary and testis.
Gene
160:195-200[Medline].
|
| 44.
|
Malkova, A.,
E. L. Ivanov, and J. E. Haber.
1996.
Double-strand break repair in the absence of RAD51 in yeast: a possible role for break-induced DNA replication.
Proc. Natl. Acad. Sci. USA
93:7131-7136[Abstract/Free Full Text].
|
| 45.
|
McCloskey, T. W.,
N. Oyaizu,
M. Coronesi, and S. Pahwa.
1994.
Use of a flow cytometric assay to quantitate apoptosis in human lymphocytes.
Clin. Immunol. Immunopathol.
71:14-18[Medline].
|
| 46.
|
New, J. H.,
T. Sugiyama,
E. Zaitseva, and S. C. Kowalczykowski.
1998.
Rad52 protein stimulates DNA strand exchange by Rad51 and replication protein A.
Nature
391:407-410[Medline].
|
| 47.
|
Nicholson, D. W.,
A. Ali,
N. A. Thornberry,
J. P. Vaillancourt,
C. K. Ding,
M. Gallant,
Y. Gareau,
P. R. Griffin,
M. Labelle,
Y. A. Lazebnik,
N. A. Munday,
S. M. Raju,
M. E. Smulson,
T.-T. Yamin,
V. L. Yu, and D. K. Miller.
1995.
Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis.
Nature
376:37-43[Medline].
|
| 48.
|
Nicholson, D. W., and N. A. Thornberry.
1997.
Caspases: killer proteases.
Trends Biochem. Sci.
22:299-306[Medline].
|
| 49.
|
Ogawa, T.,
X. Yu,
A. Shinohara, and E. H. Egelman.
1993.
Similarity of the yeast Rad51 filament to the bacterial RecA filament.
Science
259:1896-1899[Abstract/Free Full Text].
|
| 50.
|
Ohtsu, M.,
N. Sakai,
H. Fujita,
M. Kashiwagi,
S. Gasa,
S. Shimuzu,
Y. Eguchi,
Y. Tsujimoto,
Y. Sakiyama,
K. Kobayashi, and N. Kuzumaki.
1997.
Inhibition of apoptosis by the actin-regulatory protein gelsolin.
EMBO J.
16:4650-4656[Medline].
|
| 51.
|
Pai, J. T.,
M. S. Brown, and J. L. Goldstein.
1996.
Purification and cDNA cloning of a second apoptosis-related cysteine protease that cleaves and activates sterol regulatory element binding proteins.
Proc. Natl. Acad. Sci. USA
93:5437-5442[Abstract/Free Full Text].
|
| 52.
|
Park, D. S.,
L. Stefanis,
C. Y. I. Yan,
S. E. Farinelli, and L. A. Greene.
1996.
Ordering the cell death pathway.
J. Biol. Chem.
271:21898-21905[Abstract/Free Full Text].
|
| 53.
|
Park, M. S.
1995.
Expression of human RAD52 confers resistance to ionizing radiation in mammalian cells.
J. Biol. Chem.
270:15467-15470[Abstract/Free Full Text].
|
| 54.
|
Pronk, G. J.,
K. Ramer,
P. Amiri, and L. T. Williams.
1996.
Requirement of an ICE-like protease for induction of apoptosis and ceramide generation by REAPER.
Science
271:808-810[Abstract].
|
| 55.
|
Rabizadeh, S. D.,
D. J. LaCount,
P. D. Friensen, and D. E. Bredesen.
1993.
Expression of the baculovirus p35 gene inhibits mammalian neural cell death.
J. Neurochem.
61:2318-2321[Medline].
|
| 56.
|
Rao, L.,
D. Perez, and E. White.
1996.
Lamin proteolysis facilitates nuclear events during apoptosis.
J. Cell Biol.
135:1441-1455[Abstract/Free Full Text].
|
| 57.
|
Ray, C. A.,
R. A. Black,
S. R. Kronheim,
T. A. Greenstreet,
P. R. Sleath,
G. S. Salvesen, and D. J. Pickup.
1992.
Viral inhibition of inflammation: cowpox virus encodes an inhibitor of the interleukin-1 -converting enzyme.
Cell
69:597-604[Medline].
|
| 58.
|
Rudel, T., and G. M. Bokoch.
1997.
Membrane and morphological changes in apoptotic cells regulated by caspase-mediated activation of PAK2.
Science
276:1571-1574[Abstract/Free Full Text].
|
| 59.
|
Scully, R.,
J. Chen,
A. Plug,
Y. Xiao,
D. Weaver,
J. Feunteun,
T. Ashley, and D. M. Livingston.
1997.
Association of BRCA1 with Rad51 in mitotic and meiotic cells.
Cell
88:265-275[Medline].
|
| 60.
|
Shinohara, A.,
H. Ogawa,
Y. Matsuda,
N. Ushio,
K. Ikeo, and T. Ogawa.
1993.
Cloning of human, mouse and fission yeast recombination genes homologous to RAD51 and recA.
Nat. Genet.
4:239-243[Medline].
|
| 61.
|
Shinohara, A.,
H. Ogawa, and T. Ogawa.
1992.
Rad51 protein involved in repair and recombination in Saccharomyces cerevisiae is a RecA-like protein.
Cell
69:457-470[Medline].
|
| 62.
|
Shinohara, A., and T. Ogawa.
1995.
Homologous recombination and the roles of double-strand breaks.
Trends Biochem. Sci.
20:387-391[Medline].
|
| 63.
|
Shinohara, A., and T. Ogawa.
1998.
Stimulation by Rad51 of yeast Rad51-mediated recombination.
Nature
391:404-407[Medline].
|
| 64.
|
Sonoda, E.,
M. S. Sasaki,
J.-M. Buerstedde,
O. Bezzubova,
A. Shinohara,
H. Ogawa,
M. Takata,
Y. Yamaguchi-Iwai, and S. Takeda.
1998.
Rad51-deficient vertebrate cells accumulate chromosomal breaks prior to cell death.
EMBO J.
17:598-608[Medline].
|
| 65.
|
Stürzbecher, H.-W.,
B. Donzelmann,
W. Henning,
U. Knippschild, and S. Buchhop.
1996.
p53 is linked directly to homologous recombination processes via RAD51/RecA protein interaction.
EMBO J.
15:1992-2002[Medline].
|
| 66.
|
Sung, P.
1997.
Function of yeast Rad52 protein as a mediator between replication protein A and the Rad51 recombinase.
J. Biol. Chem.
272:28194-28197[Abstract/Free Full Text].
|
| 67.
|
Sung, P.
1997.
Yeast Rad55 and Rad57 proteins form a heterodimer that functions with replication protein A to promote DNA strand exchange by Rad51 recombinase.
Genes Dev.
11:1111-1121[Abstract/Free Full Text].
|
| 68.
|
Sung, P., and D. L. Robberson.
1995.
DNA strand exchange mediated by a Rad51-ssDNA nucleoprotein filament with polarity opposite to that of RecA.
Cell
82:453-461[Medline].
|
| 69.
|
Taki, T.,
T. Ohnishi,
A. Yamamoto,
S. Hiraga,
N. Arita,
S. Izumoto,
T. Hayakawa, and T. Morita.
1996.
Antisense inhibition of the RAD51 enhances radiosensitivity.
Biochem. Biophys. Res. Commun.
223:434-438[Medline].
|
| 70.
|
Talanian, R. V.,
C. Quinlan,
S. Trautz,
M. C. Hackett,
J. A. Mankovich,
D. Banach,
T. Ghayur,
K. D. Brady, and W. W. Wong.
1997.
Substrate specificities of caspase family proteases.
J. Biol. Chem.
272:9677-9682[Abstract/Free Full Text].
|
| 71.
|
Tewari, M., and V. M. Dixit.
1995.
Fas- and tumor necrosis factor-induced apoptosis is inhibited by the poxvirus crmA gene product.
J. Biol. Chem.
270:3255-3260[Abstract/Free Full Text].
|
| 72.
|
Thornberry, N. A.,
T. A. Rano,
E. P. Peterson,
D. M. Rasper,
T. Timkey,
M. Garcia-Calvo,
V. M. Houtzager,
P. A. Nordstrom,
S. Roy,
J. P. Vaillancourt,
K. T. Chapman, and D. W. Nicholson.
1997.
A combinatorial approach defines specificities of members of the caspase family and granzyme B. Functional relationships established for key mediators of apoptosis.
J. Biol. Chem.
272:17907-17911[Abstract/Free Full Text].
|
| 73.
|
Tsuzuki, T.,
Y. Fujii,
K. Sakumi,
Y. Tominaga,
K. Nakao,
M. Sekiguchi,
A. Matsushiro,
Y. Yoshimura, and T. Morita.
1996.
Targeted disruption of the Rad51 gene leads to lethality in embryonic mice.
Proc. Natl. Acad. Sci. USA
93:6236-6240[Abstract/Free Full Text].
|
| 74.
|
Villa, P.,
S. H. Kaufmann, and W. C. Earnshaw.
1997.
Caspases and caspase inhibitors.
Trends Biochem. Sci.
22:388-393[Medline].
|
| 75.
|
Wang, Z.-Q.,
B. Auer,
L. Stingl,
H. Berghammer,
D. Haidacher,
M. Schweiger, and E. F. Wagner.
1995.
Mice lacking ADPRT and poly(ADP-ribosyl)ation develop normally but are susceptible to skin disease.
Genes Dev.
9:509-520[Abstract/Free Full Text].
|
| 76.
|
Wissing, D.,
H. Mouritzen,
M. Egeblad,
G. G. Poirier, and M. Jaattela.
1997.
Involvement of caspase-dependent activation of cystolic phospholipase A2 in tumor necrosis factor-induced apoptosis.
Proc. Natl. Acad. Sci. USA
94:5073-5077[Abstract/Free Full Text].
|
| 77.
|
Xue, D., and H. R. Horwitz.
1995.
Inhibition of the Caenorhabditis elegans cell-death protease CED-3 by a CED-3 cleavage site in baculovirus p35 protein.
Nature
377:248-251[Medline].
|
| 78.
|
Yang, J.,
X. Liu,
K. Bhalla,
C. Kaekyung Kim,
A. M. Ibrado,
J. Cai,
T.-I. Peng,
D. P. Jones, and X. Wang.
1997.
Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked.
Science
275:1129-1132[Abstract/Free Full Text].
|
| 79.
|
Yuan, Z.-M.,
Y. Huang,
T. Ishiko,
S. Kharbanda,
R. Weichselbaum, and D. Kufe.
1997.
Regulation of DNA damage-induced apoptosis by the c-Abl tyrosine kinase.
Proc. Natl. Acad. Sci. USA
94:1437-1440[Abstract/Free Full Text].
|
| 80.
|
Yuan, Z. M.,
Y. Huang,
T. Ishiko,
S. Nakada,
T. Utsugisawa,
S. Kharbanda,
P. Sung,
A. Shinohara,
R. Weichselbaum, and D. Kufe.
1998.
Regulation of Rad51 function by c-Abl in response to DNA damage.
J. Biol. Chem.
273:3799-3802[Abstract/Free Full Text].
|
| 81.
|
Yuan, Z. M.,
Y. Huang,
Y. Whang,
C. Sawyers,
R. Weichselbaum,
S. Kharbanda, and D. Kufe.
1996.
Role for the c-Abl tyrosine kinase in the growth arrest response to DNA damage.
Nature
382:272-274[Medline].
|
| 82.
|
Zhou, Q.,
S. Snipar,
K. Orth,
M. Muzio,
V. M. Dixit, and G. S. Salvesen.
1997.
Target protease specificity of the viral Serpin CrmA.
J. Biol. Chem.
272:7797-7800[Abstract/Free Full Text].
|
Molecular and Cellular Biology, April 1999, p. 2986-2997, Vol. 19, No. 4
0270-7306/99/$04.00+0
Copyright © 1999, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Bolderson, E., Richard, D. J., Edelmann, W., Khanna, K. K.
(2009). Involvement of Exo1b in DNA damage-induced apoptosis. Nucleic Acids Res
37: 3452-3463
[Abstract]
[Full Text]
-
Adimoolam, S., Sirisawad, M., Chen, J., Thiemann, P., Ford, J. M., Buggy, J. J.
(2007). HDAC inhibitor PCI-24781 decreases RAD51 expression and inhibits homologous recombination. Proc. Natl. Acad. Sci. USA
104: 19482-19487
[Abstract]
[Full Text]
-
Valenti, A., Napoli, A., Ferrara, M. C., Nadal, M., Rossi, M., Ciaramella, M.
(2006). Selective degradation of reverse gyrase and DNA fragmentation induced by alkylating agent in the archaeon Sulfolobus solfataricus.. Nucleic Acids Res
34: 2098-2108
[Abstract]
[Full Text]
-
Weinberger, M., Ramachandran, L., Feng, L., Sharma, K., Sun, X., Marchetti, M., Huberman, J. A., Burhans, W. C.
(2005). Apoptosis in budding yeast caused by defects in initiation of DNA replication. J. Cell Sci.
118: 3543-3553
[Abstract]
[Full Text]
-
Smith, J. J., Cole, E. S., Romero, D. P.
(2004). Transcriptional control of RAD51 expression in the ciliate Tetrahymena thermophila. Nucleic Acids Res
32: 4313-4321
[Abstract]
[Full Text]
-
Chen, F., Arseven, O. K., Cryns, V. L.
(2004). Proteolysis of the Mismatch Repair Protein MLH1 by Caspase-3 Promotes DNA Damage-induced Apoptosis. J. Biol. Chem.
279: 27542-27548
[Abstract]
[Full Text]
-
Pati, D., Zhang, N., Plon, S. E.
(2002). Linking Sister Chromatid Cohesion and Apoptosis: Role of Rad21. Mol. Cell. Biol.
22: 8267-8277
[Abstract]
[Full Text]
-
Bordone, L., Campbell, C.
(2002). DNA Ligase III Is Degraded by Calpain during Cell Death Induced by DNA-damaging Agents. J. Biol. Chem.
277: 26673-26680
[Abstract]
[Full Text]
-
Chen, F., Kamradt, M., Mulcahy, M., Byun, Y., Xu, H., McKay, M. J., Cryns, V. L.
(2002). Caspase Proteolysis of the Cohesin Component RAD21 Promotes Apoptosis. J. Biol. Chem.
277: 16775-16781
[Abstract]
[Full Text]
-
Wiese, C., Pierce, A. J., Gauny, S. S., Jasin, M., Kronenberg, A.
(2002). Gene Conversion Is Strongly Induced in Human Cells by Double-strand Breaks and Is Modulated by the Expression of BCL-xL. Cancer Res.
62: 1279-1283
[Abstract]
[Full Text]
-
Raderschall, E., Stout, K., Freier, S., Suckow, V., Schweiger, S., Haaf, T.
(2002). Elevated Levels of Rad51 Recombination Protein in Tumor Cells. Cancer Res.
62: 219-225
[Abstract]
[Full Text]
-
Vasquez, K. M., Marburger, K., Intody, Z., Wilson, J. H.
(2001). Manipulating the mammalian genome by homologous recombination. Proc. Natl. Acad. Sci. USA
98: 8403-8410
[Abstract]
[Full Text]
-
Noah, D. L., Blum, M. A., Sherry, B.
(1999). Interferon Regulatory Factor 3 Is Required for Viral Induction of Beta Interferon in Primary Cardiac Myocyte Cultures. J. Virol.
73: 10208-10213
[Abstract]
[Full Text]
-
Bischof, O., Galande, S., Farzaneh, F., Kohwi-Shigematsu, T., Campisi, J.
(2001). Selective Cleavage of BLM, the Bloom Syndrome Protein, during Apoptotic Cell Death. J. Biol. Chem.
276: 12068-12075
[Abstract]
[Full Text]